JPMORGAN CHASE & CO - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 59 filers reported holding ADMA BIOLOGICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.9%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$670,648
+3.6%
187,332
+6.8%
0.00%
Q2 2023$647,351
+12.2%
175,434
+0.7%
0.00%
Q1 2023$577,000
+52117.2%
174,224
-38.8%
0.00%
Q4 2022$1,105
-99.6%
284,908
+159.0%
0.00%
Q3 2022$268,000
+25.2%
109,996
+1.8%
0.00%
Q2 2022$214,000
+48.6%
108,094
+36.6%
0.00%
Q1 2022$144,000
+500.0%
79,106
+360.0%
0.00%
Q4 2021$24,000
-82.2%
17,197
-79.6%
0.00%
Q2 2021$135,000
+53.4%
84,099
+66.7%
0.00%
Q1 2021$88,000
+3.5%
50,456
+15.8%
0.00%
Q4 2020$85,000
+73.5%
43,557
+94.1%
0.00%
Q3 2020$49,000
-16.9%
22,437
+10.8%
0.00%
Q2 2020$59,000
-9.2%
20,251
-10.5%
0.00%
Q1 2020$65,000
-1.5%
22,636
+37.2%
0.00%
Q4 2019$66,000
-91.0%
16,500
-90.0%
0.00%
Q3 2019$732,000
+2514.3%
164,529
+2091.1%
0.00%
Q2 2019$28,000
+16.7%
7,509
+20.1%
0.00%
Q1 2019$24,000
-66.7%
6,250
-79.1%
0.00%
Q4 2018$72,000
-94.9%
29,904
-86.9%
0.00%
Q3 2018$1,422,000
+113.2%
228,999
+54.7%
0.00%
Q2 2018$667,000
+266.5%
147,996
+274.8%
0.00%
Q1 2018$182,00039,4910.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 9,104,275$32,593,30510.83%
Altium Capital Management LP 2,723,011$9,748,3795.08%
Velan Capital Investment Management LP 1,736,100$6,215,2385.01%
AWM Investment Company, Inc. 5,999,872$21,479,5423.17%
Mesirow Financial Investment Management, Inc. 72,677$260,1841.13%
Caligan Partners LP 597,513$2,139,0970.98%
Perceptive Advisors 6,984,319$25,003,8620.83%
OBERWEIS ASSET MANAGEMENT INC/ 2,078,400$7,440,6720.79%
TANG CAPITAL MANAGEMENT LLC 1,360,000$4,868,8000.69%
EAM Investors, LLC 967,146$3,462,3830.67%
View complete list of ADMA BIOLOGICS INC shareholders